4 results
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
To investigate if jerks and psychiatric disorders in patients with dystonia are associated with a hyperdopaminergic/ hyposerotonergic system and whether reversal of a hyposerotonergic state has a therapeutic effect.
Approved WMOCompleted
ObjectivesPrimary Efficacy Objective• To assess the sustained clinical effect of BM32 during 2 consecutive treatment years compared to placebo. The clinical effect of BM32 is evaluated by a combined Symptom-Medication-Score (SMS) which is recorded…